Nuvalent Newsroom

J.P. Morgan Reaffirms Their Buy Rating on Nuvalent (NUVL)

TipRanksNov 21 07:07 ET

Nuvalent's Promising ALK and ROS1 Programs Drive Buy Rating Amid Strong Financial Position and Upcoming Trials

TipRanksNov 14 02:37 ET

TD Cowen Maintains Nuvalent(NUVL.US) With Buy Rating

Moomoo NewsNov 13 08:36 ET

BMO Capital Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $134

Moomoo NewsNov 13 08:36 ET

Stifel Maintains Nuvalent(NUVL.US) With Buy Rating, Cuts Target Price to $132

Moomoo NewsNov 13 08:36 ET

Nuvalent Is Maintained at Outperform by BMO Capital

Dow JonesNov 13 08:14 ET

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $134

Moomoo NewsNov 13 08:06 ET

Nuvalent Analyst Ratings

BenzingaNov 13 08:04 ET

Barclays Remains a Buy on Nuvalent (NUVL)

TipRanksNov 13 05:17 ET

Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Nuvalent (NUVL)

TipRanksNov 12 19:42 ET

Nuvalent: Strategic Progress and Pipeline Advancements Solidify Buy Rating

TipRanksNov 12 11:08 ET

Nuvalent Initiated With a Neutral at UBS

TipRanksOct 24 05:40 ET

Nuvalent Is Maintained at Overweight by JP Morgan

Dow JonesOct 4 14:35 ET

Nuvalent Analyst Ratings

BenzingaOct 4 14:26 ET

J.P. Morgan Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $125

Moomoo NewsOct 4 07:31 ET

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Moomoo NewsSep 17 09:00 ET

Nuvalent Price Target Raised to $132.00/Share From $102.00 by BMO Capital

Dow JonesSep 16 09:04 ET

A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $135

Moomoo NewsSep 16 09:00 ET

Nuvalent Is Maintained at Buy by Stifel

Dow JonesSep 16 08:12 ET

Nuvalent Analyst Ratings

BenzingaSep 16 08:03 ET